Their last game was a close one until Calhoun started hitting from beyond the 3-point line.

NPR: Connecticut Beats No. 6 Syracuse 66-58

The Quad is a once-a-day pill that aims to provide Gilead with a revenue stream that will last beyond the patent expiration of its key drug Viread and its current one-a-day, Atripla.

FORBES: FDA Weighs In On Gilead's Crucial Pill

In the last of our four-part Beyond the Balance Sheet series, we review one consultant's scorecard on how big corporations act as citizens.

FORBES: Benchmarking Benevolence